Lærke Smidt Gasbjerg

About Lærke Smidt Gasbjerg

Lærke Smidt Gasbjerg, With an exceptional h-index of 26 and a recent h-index of 25 (since 2020), a distinguished researcher at Københavns Universitet,

His recent articles reflect a diverse array of research interests and contributions to the field:

The impact of type 2 diabetes and glycaemic control on mortality and clinical outcomes in hospitalized patients with COVID‐19 in the capital region of Denmark

Intestinal Expression Profiles and Hepatic Expression of LEAP2, Ghrelin and their Common Receptor, GHSR, in Humans

Safety of native glucose-dependent insulinotropic polypeptide in humans

GIP-derived GIP receptor antagonists–a review of their role in GIP receptor pharmacology

Effects of exogenous GIP and GLP-2 on bone turnover in individuals with type 2 diabetes

Protocol: Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double …

The importance of endogenously secreted GLP-1 and GIP for postprandial glucose tolerance and β-cell function after Roux-en-Y gastric bypass and sleeve gastrectomy surgery

Altered desensitization and internalization patterns of rodent versus human GIP receptors--a major drug discovery challenge

Lærke Smidt Gasbjerg Information

University

Position

___

Citations(all)

1868

Citations(since 2020)

1641

Cited By

830

hIndex(all)

26

hIndex(since 2020)

25

i10Index(all)

40

i10Index(since 2020)

40

Email

University Profile Page

Google Scholar

Top articles of Lærke Smidt Gasbjerg

Title

Journal

Author(s)

Publication Date

The impact of type 2 diabetes and glycaemic control on mortality and clinical outcomes in hospitalized patients with COVID‐19 in the capital region of Denmark

Diabetes, Obesity and Metabolism

Vivian Kliim‐Hansen

Karl S Johansson

Lærke S Gasbjerg

Espen Jimenez‐Solem

Tonny S Petersen

...

2024/1

Intestinal Expression Profiles and Hepatic Expression of LEAP2, Ghrelin and their Common Receptor, GHSR, in Humans

Peptides

Anders Englund

Hannah Gilliam-Vigh

Malte P Suppli

Lærke S Gasbjerg

Tina Vilsbøll

...

2024/4/22

Safety of native glucose-dependent insulinotropic polypeptide in humans

Mads M Helsted

Nina L Schaltz

Lærke S Gasbjerg

Mikkel B Christensen

Tina Vilsbøll

...

2024/4/12

GIP-derived GIP receptor antagonists–a review of their role in GIP receptor pharmacology

Mette Marie Rosenkilde

Peter Lindquist

Hüsün Sheyma Kizilkaya

Lærke Smidt Gasbjerg

2024/4/10

Effects of exogenous GIP and GLP-2 on bone turnover in individuals with type 2 diabetes

The Journal of Clinical Endocrinology & Metabolism

Kirsa Skov-Jeppesen

Charlotte B Christiansen

Laura S Hansen

Johanne A Windeløv

Nora Hedbäck

...

2024/1/13

Protocol: Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double …

BMJ Open

Mads M Helsted

Lærke S Gasbjerg

Tina Vilsbøll

Casper K Nielsen

Julie L Forman

...

2023

The importance of endogenously secreted GLP-1 and GIP for postprandial glucose tolerance and β-cell function after Roux-en-Y gastric bypass and sleeve gastrectomy surgery

Diabetes

Morten Hindsø

Nora Hedbäck

Maria S Svane

Andreas Møller

Christoffer Martinussen

...

2023/3/1

Altered desensitization and internalization patterns of rodent versus human GIP receptors--a major drug discovery challenge

Lærke Gasbjerg

Rasmus Rasmussen

Adrian Dragan

Peter Lindquist

Josefine Melchiorsen

...

2023/7/3

Biased GLP‐2 agonist with strong G protein‐coupling but impaired arrestin recruitment and receptor desensitization enhances intestinal growth in mice

British Journal of Pharmacology

Maria Buur Nordskov Gabe

Liv von Voss

Jenna Elizabeth Hunt

Sarina Gadgaard

Lærke Smidt Gasbjerg

...

2023/7

Long-acting GIP peptide analogues

2023/2/7

The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide

Lærke S Gasbjerg

Mette M Rosenkilde

Juris J Meier

Jens J Holst

Filip K Knop

2023/11

Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double-blind …

BMJ open

Mads M Helsted

Lærke S Gasbjerg

Tina Vilsbøll

Casper K Nielsen

Julie L Forman

...

2023/2/1

285-LB: LEAP2 Reduces Preprandial and Postprandial Glucose Levels and Ad Libitum Food Intake in Obese Men

Diabetes

ANDERS ENGLUND

CHRISTOFFER A HAGEMANN

LÆRKE S GASBJERG

FILIP K KNOP

2023/6/20

Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic Phenotypes

The Journal of Clinical Endocrinology & Metabolism

Josefine U Melchiorsen

Kimmie V Sørensen

Jette Bork-Jensen

Hüsün S Kizilkaya

Lærke S Gasbjerg

...

2023/11

The gut-bone axis in diabetes

Henrik Maagensen

Mads M Helsted

Lærke S Gasbjerg

Tina Vilsbøll

Filip K Knop

2023/2

Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetes

Bone

Niels B Dalsgaard

Lærke S Gasbjerg

Mads M Helsted

Laura S Hansen

Nina L Hansen

...

2023/5/1

Extrapancreatic effects of endogenous incretin hormones evaluated using incretin hormone receptor antagonists in totally pancreatectomised patients

Diabetologia

L Krogh

CK Nielsen

NC Bergmann

JJ Holst

A Lund

...

2023/9/1

The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans

European Journal of Endocrinology

Liva SL Krogh

Kristine Henriksen

Signe Stensen

Kirsa Skov-Jeppesen

Natasha C Bergmann

...

2023/1/10

Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake

STAR protocols

Christoffer A Hagemann

Lærke S Gasbjerg

Mikkel B Christensen

Filip K Knop

2023/3/17

Peptide dual agonists of GIPR and GLP2R

2023/8/15

See List of Professors in Lærke Smidt Gasbjerg University(Københavns Universitet)